# Dyad Oxytocin Study (DOS)

> **NCT02302209** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 104 (actual)

## Conditions studied

- Schizophrenia
- Autism Spectrum Disorder

## Interventions

- **DRUG:** Oxytocin
- **OTHER:** Placebo Comparator

## Key facts

- **NCT ID:** NCT02302209
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2019-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02302209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02302209, "Dyad Oxytocin Study (DOS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02302209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*